| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Business Officer
1 company
Mitchener Stephen is a SVP, Chief Business Officer at Karyopharm Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | KPTI Karyopharm Therapeutics Inc. | SVP, Chief Business Officer | Sell | 6,357 | $3.03 | $19,256.62 | -4.7% | -28.2% | -62.5% | |
| Dec 2, 2021 | KPTI Karyopharm Therapeutics Inc. | SVP, Chief Business Officer | Sell | 499 | $6.69 | $3,338.31 | -13.1% | -14.0% | -29.3% | |
| Jun 2, 2021 | KPTI Karyopharm Therapeutics Inc. | SVP, Chief Business Officer | Sell | 528 | $9.29 | $4,905.12 | -17.6% | -37.4% | -34.1% |